Literature DB >> 10945372

The value of reporting therapeutic ineffectiveness as an adverse drug reaction.

R H Meyboom1, M Lindquist, A K Flygare, C Biriell, I R Edwards.   

Abstract

Therapeutic ineffectiveness is a frequent drug-related problem that can occur in a variety of different situations and be caused by different mechanisms. Examples are inappropriate use, interactions or metabolic abnormalities. Observations in patients of unexpected ineffectiveness can provide important information with regard to such situations. Therefore, ineffectiveness--especially when unexpected or unexplained--is a potentially important reportable event in pharmacovigilance. The terms regarding ineffectiveness in the WHO Adverse Reaction Terminology (WHOART) have been recently revised in order to enable optimal coding of such case reports.

Entities:  

Mesh:

Year:  2000        PMID: 10945372     DOI: 10.2165/00002018-200023020-00001

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  3 in total

1.  Drugs, money and society.

Authors:  T Walley
Journal:  Br J Clin Pharmacol       Date:  1995-04       Impact factor: 4.335

2.  Drug-related hospital admissions.

Authors:  K M Nelson; R L Talbert
Journal:  Pharmacotherapy       Date:  1996 Jul-Aug       Impact factor: 4.705

Review 3.  Harmonisation in pharmacovigilance.

Authors:  I R Edwards; C Biriell
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606

  3 in total
  8 in total

1.  Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBase.

Authors:  Kristina Star; G Niklas Norén; Karin Nordin; I Ralph Edwards
Journal:  Drug Saf       Date:  2011-05-01       Impact factor: 5.606

2.  Therapeutic ineffectiveness: heads or tails?

Authors:  Albert Figueras; Consuelo Pedrós; Mabel Valsecia; Joan-Ramon Laporte
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

3.  Reporting patterns indicative of adverse drug interactions: a systematic evaluation in VigiBase.

Authors:  Johanna Strandell; Ola Caster; Andrew Bate; Niklas Norén; I Ralph Edwards
Journal:  Drug Saf       Date:  2011-03-01       Impact factor: 5.606

4.  Signal of Gastrointestinal Congenital Malformations with Antipsychotics After Minimising Competition Bias: A Disproportionality Analysis Using Data from Vigibase(®).

Authors:  François Montastruc; Francesco Salvo; Mickaël Arnaud; Bernard Bégaud; Antoine Pariente
Journal:  Drug Saf       Date:  2016-07       Impact factor: 5.606

5.  The development and evaluation of triage algorithms for early discovery of adverse drug interactions.

Authors:  Johanna Strandell; Ola Caster; Johan Hopstadius; I Ralph Edwards; G Niklas Norén
Journal:  Drug Saf       Date:  2013-05       Impact factor: 5.606

6.  Detection of adverse drug events in e-prescribing and administrative health data: a validation study.

Authors:  Bettina Habib; Robyn Tamblyn; Nadyne Girard; Tewodros Eguale; Allen Huang
Journal:  BMC Health Serv Res       Date:  2021-04-23       Impact factor: 2.655

7.  Evaluation of patients' experiences with antidepressants reported by means of a medicine reporting system.

Authors:  E C G van Geffen; S W van der Wal; R van Hulten; M C H de Groot; A C G Egberts; E R Heerdink
Journal:  Eur J Clin Pharmacol       Date:  2007-09-15       Impact factor: 2.953

8.  Pharmacovigilance of suspected or confirmed therapeutic ineffectiveness of artemisinin-based combination therapy: extent, associated factors, challenges and solutions to reporting.

Authors:  Ronald Kiguba; Helen Byomire Ndagije; Victoria Nambasa; Leonard Manirakiza; Elijah Kirabira; Allan Serwanga; Sten Olsson; Niko Speybroeck; Jackson Mukonzo
Journal:  Malar J       Date:  2020-11-03       Impact factor: 2.979

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.